Ecrins Therapeutics Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $4.23M
Latest Deal Amount
  • Investors
  • 1

Ecrins Therapeutics General Information


Operator of a biotech company intended to discover and develop new therapies to treat and cure patients suffering from deadly and debilitating diseases. The company's technology robs the tumors of oxygen and nutrients and causes cancer cells to die, enabling patients to get small molecules active against several oncology indications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • BioPolis
  • 5 avenue du Grand Sablon
  • 38700 La Tronche
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ecrins Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant $4.23M 00.000 Completed Generating Revenue
3. Equity Crowdfunding 01-Jan-2017 00000 00.000 Completed Generating Revenue
2. Equity Crowdfunding 10-May-2015 $585K $585K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Ecrins Therapeutics’s complete valuation and funding history, request access »

Ecrins Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Andreï Popov Ph.D Co-Founder, President & Chief Executive Officer
Aurélie Juhem Ph.D Co-Founder & Chief Operating Officer
Francois Berger Ph.D Co-Founder & Member of Scientific Advisory Board
To view Ecrins Therapeutics’s complete executive team members history, request access »

Ecrins Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ecrins Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GATE1 Accelerator/Incubator 000 0000 000000 0
To view Ecrins Therapeutics’s complete investors history, request access »